These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 1553883
1. Proarrhythmic effects of antiarrhythmic drugs: evolving concepts. Morganroth J. Am Heart J; 1992 Apr; 123(4 Pt 2):1137-9. PubMed ID: 1553883 [Abstract] [Full Text] [Related]
2. Early and late proarrhythmia from antiarrhythmic drug therapy. Morganroth J. Cardiovasc Drugs Ther; 1992 Feb; 6(1):11-4. PubMed ID: 1533532 [Abstract] [Full Text] [Related]
4. [The pro-arrhythmic effects of anti-arrhythmia agents]. Haverkamp W, Wichter T, Chen X, Hördt M, Willems S, Rotman B, Hindricks G, Kottkamp H, Borggrefe M, Breithardt G. Z Kardiol; 1994 Feb; 83 Suppl 5():75-85. PubMed ID: 7846949 [Abstract] [Full Text] [Related]
5. Proarrhythmic effects of antiarrhythmic drugs. Ross DL, Cooper MJ, Koo CC, Skinner MP, Davis LM, Richards DA, Uther JB. Med J Aust; 1990 Jul 02; 153(1):37-47. PubMed ID: 2199804 [Abstract] [Full Text] [Related]
6. Prevalence and characteristics of proarrhythmia from moricizine (Ethmozine). Morganroth J, Pratt CM. Am J Cardiol; 1989 Jan 15; 63(3):172-6. PubMed ID: 2642632 [Abstract] [Full Text] [Related]
7. Clinical types of proarrhythmic response to antiarrhythmic drugs. Bigger JT, Sahar DI. Am J Cardiol; 1987 Apr 30; 59(11):2E-9E. PubMed ID: 3554950 [Abstract] [Full Text] [Related]
8. Drug-induced early and late proarrhythmia. Morganroth J. Cardiol Clin; 1992 Aug 30; 10(3):397-401. PubMed ID: 1504971 [Abstract] [Full Text] [Related]
9. Proarrhythmia: a paradoxic response to antiarrhythmic agents. McCollam PL, Parker RB, Beckman KJ, Hariman RJ, Bauman JL. Pharmacotherapy; 1989 Aug 30; 9(3):144-53. PubMed ID: 2666959 [Abstract] [Full Text] [Related]
10. Proarrhythmic response to antiarrhythmic drug as a risk factor for sudden cardiac death in patients with ischemic heart disease. Trusz-Gluza M, Giec L, Dabrowski A, Kuch J, Pasyk S, Piwowarska W, Pracka H, Sadowski Z, Wodniecki J. Pacing Clin Electrophysiol; 1991 Nov 30; 14(11 Pt 2):1947-50. PubMed ID: 1721204 [Abstract] [Full Text] [Related]
11. [Antiarrhythmic therapy in patients with heart failure]. Faber TS, Zehender M. Ther Umsch; 2000 May 30; 57(5):324-32. PubMed ID: 10859993 [Abstract] [Full Text] [Related]
12. [Cardiac side effects of anti-arrhythmia agents]. Seipel L. Z Kardiol; 1988 Feb 30; 77(2):77-88. PubMed ID: 3284219 [Abstract] [Full Text] [Related]
13. Can antiarrhythmic drugs survive survival trials? Pratt CM, Waldo AL, Camm AJ. Am J Cardiol; 1998 Mar 19; 81(6A):24D-34D. PubMed ID: 9537220 [Abstract] [Full Text] [Related]
14. Experimental evidence for proarrhythmic mechanisms of antiarrhythmic drugs. Nattel S. Cardiovasc Res; 1998 Mar 19; 37(3):567-77. PubMed ID: 9659440 [Abstract] [Full Text] [Related]
15. Proarrhythmia, a serious complication of antiarrhythmic drugs. Podrid PJ. Curr Cardiol Rep; 1999 Nov 19; 1(4):289-96. PubMed ID: 10980856 [Abstract] [Full Text] [Related]
16. Proarrhythmia during drug treatment of supraventricular tachycardia: paradoxical risk of sinus rhythm for sudden death. Prystowsky EN. Am J Cardiol; 1996 Oct 17; 78(8A):35-41. PubMed ID: 8903274 [Abstract] [Full Text] [Related]
17. Antiarrhythmic therapy for ventricular arrhythmias. Zimmermann M. J Cardiovasc Pharmacol; 1991 Oct 17; 17 Suppl 6():S59-64. PubMed ID: 1723121 [Abstract] [Full Text] [Related]